|
Forest Laboratories |
Details
|
Forest Laboratories is a pharmaceutical company focusing on the production, manufacturing, and distribution of non-prescription and prescription pharmaceutical products in the United States and United Kingdom. The major products include: Celexa, Namenda, Lexapro, Benicar, Benicar HCT, Tidzac, CCR1, Milnacipran, Neramexane, Acamprosate, Aerobid, and Lercanidipine. Forest Labaratories’ products Celexa and Lexapro are prescribed to treat depressive disorders. Namenda is used for the treatment of moderate to severe Alzheimer’s Disease. Benicar, Benicar HCT, Lercanidipine, and Tiazac are directed to cure hypertension. Forest Labaratory drug Aerobid is an inhaled steroid and is prescribed to treat asthma. The drug Neramexane is a NMDA receptor antagonist, currently in phase 2 clinical study and would be used for different CNS disorders. Milnacipran is in phase 3 clinical trials as of now and is designed for treatment of Fibromyalgia Syndrome. Acamprosate is prescribed to cure alcohol addictions. The product CCR1 is a chemokine receptor that involves the inflammation process. Forest Laboratories distributes its products to hospitals, doctors, pharmacies, managed care, and other healthcare businesses. The company was established in 1956 and is based in New York City, New York. The company is publicly traded on the New York Stock Exchange under the symbol: FRX.
|
| Category |
Pharmaceutical Companies > F
|
| Related Searches |
forest laboratory inc, forest products |
| Date Submitted |
20-Aug-2005
|
|
